A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations: Table 1
Jamie Wilson(Princess Anne Hospital), Diana Eccles(Princess Anne Hospital), J. Louise Jones(Queen Mary University of London), Helen Hanson(University of Exeter), Nazneen Rahman(Royal Marsden NHS Foundation Trust), Qi An(University of Southampton), D. Gareth Evans(Institute of Cancer Research), Adrian C Bateman(Southampton General Hospital)
Cited by 119
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
|Nature Genetics|2015|634
A common coding variant in CASP8 is associated with breast cancer risk
|Nature Genetics|2007|612